IP Library › Assignment 055192/0805
Patent Assignment
Reel/Frame 055192/0805

Assignment of Assignor's Interest

Recorded: 2021-02-01 Pages: 48
Assignor
CELGENE INTERNATIONAL II SÀRL
Executed: 2020-06-22
Assignee
RECEPTOS LLC
430 EAST 29TH STREET, 14TH FLOOR, NEW YORK, NEW YORK, 10016
Covered Properties (94)
Sphingosine 1 Phosphate Receptor Modulators and Methods of Chiral Synthesis
Selective Heterocyclic Sphingosine 1 Phosphate Receptor Modulators
Selective Sphingosine 1 Phosphate Receptor Modulators and Methods of Chiral Synthesis
Novel Glp-1 Receptor Stabilizers and Modulators
Selective Heterocyclic Sphingosine 1 Phosphate Receptor Modulators
Novel Fusion Partners for the Purpose of Crystallizing G-Protein Coupled Receptors
Novel Glp-1 Receptor Stabilizers and Modulators
Novel Glp-1 Receptor Modulators
Novel Glp-1 Receptor Modulators
Selective Sphingosine 1 Phosphate Receptor Modulators and Combination Therapy Therewith
Novel Glp-1 Receptor Modulators
Novel Glp-1 Receptor Modulators
CXCR3 Receptor Agonists
Compounds and Methods for Treating Lupus
Dimethylaminoethanol Salt of a Glp-1 Receptor Modulator
Novel Glp-1 Receptor Modulators
Sphingosine 1 Phosphate Receptor Agonists for Neuroprotection
Sphingosine 1 Phosphate Receptor Modulators
Sphingosine 1 Phosphate Receptor Modulators
Sphingosine 1 Phosphate Receptor Modulators
Sphingosine 1 Phosphate Receptor Modulator
Sphingosine 1 Phosphate Receptor Modulators and Methods of Chiral Synthesis
Patent: 8,357,706 →
Application: 12/946,800 →
Publication: US 2011/0178056
Selective Sphingosine 1 Phosphate Receptor Modulators and Methods of Chiral Synthesis
Patent: 8,362,048 →
Application: 12/946,819 →
Publication: US 2011/0172202
Selective Heterocyclic Sphingosine 1 Phosphate Receptor Modulators
Patent: 8,507,538 →
Application: 12/946,828 →
Publication: US 2011/0183953
Novel Glp-1 Receptor Stabilizers and Modulators
Patent: 8,501,982 →
Application: 13/157,264 →
Publication: US 2011/0306542
Novel Fusion Partners for the Purpose of Crystallizing G-Protein Coupled Receptors
Application: 13/470,104 →
Publication: US 2012/0288913
Novel Glp-1 Receptor Modulators
Patent: 8,778,923 →
Application: 13/712,624 →
Publication: US 2013/0178420
Selective Sphingosine 1 Phosphate Receptor Modulators and Methods of Chiral Synthesis
Application: 13/740,661 →
Publication: US 2013/0231326
Sphingosine 1 Phosphate Receptor Modulators and Methods of Chiral Synthesis
Application: 13/740,669 →
Publication: US 2013/0196966
Novel Glp-1 Receptor Stabilizers and Modulators
Patent: 8,816,121 →
Application: 13/936,815 →
Publication: US 2014/0031290
Selective Heterocyclic Sphingosine 1 Phosphate Receptor Modulators
Application: 13/941,695 →
Publication: US 2014/0039183
Selective Heterocyclic Sphingosine 1 Phosphate Receptor Modulators
Patent: 9,481,659 →
Application: 14/117,514 →
Publication: US 2015/0299179
Novel Glp-1 Receptor Stabilizers and Modulators
Patent: 9,278,910 →
Application: 14/122,176 →
Publication: US 2014/0336185
Novel Glp-1 Receptor Modulators
Patent: 9,187,522 →
Application: 14/296,907 →
Publication: US 2015/0038416
Novel Glp-1 Receptor Modulators
Patent: 9,260,427 →
Application: 14/302,260 →
Publication: US 2015/0011527
Selective Heterocyclic Sphingosine 1 Phosphate Receptor Modulators
Application: 14/563,742 →
Publication: US 2015/0252037
Selective Sphingosine 1 Phosphate Receptor Modulators and Methods of Chiral Synthesis
Patent: 9,388,147 →
Application: 14/632,675 →
Publication: US 2015/0299149
Sphingosine 1 Phosphate Receptor Modulators and Methods of Chiral Synthesis
Patent: 9,394,264 →
Application: 14/634,439 →
Publication: US 2015/0299150
Novel Glp-1 Receptor Modulators
Patent: 9,474,755 →
Application: 14/809,020 →
Publication: US 2016/0038487
Novel Glp-1 Receptor Modulators
Patent: 9,598,430 →
Application: 14/958,513 →
Publication: US 2016/0214993
Novel Glp-1 Receptor Modulators
Patent: 9,795,613 →
Application: 14/965,777 →
Publication: US 2016/0228450
Novel Glp-1 Receptor Stabilizers and Modulators
Patent: 9,700,543 →
Application: 14/997,364 →
Publication: US 2016/0310471
Selective Sphingosine 1 Phosphate Receptor Modulators and Combination Therapy Therewith
Application: 15/033,311 →
Publication: US 2017/0165236
Elective Sphingosine 1 Phosphate Receptor Modulators and Methods of Chiral Synthesis
Application: 15/170,686 →
Novel Glp-1 Receptor Modulators
Patent: 9,839,664 →
Application: 15/263,637 →
Publication: US 2017/0216392
Selective Sphingosine 1 Phosphate Receptor Modulators and Methods of Chiral Synthesis
Application: 15/406,128 →
Publication: US 2017/0320839
Novel Glp-1 Receptor Modulators
Application: 15/416,758 →
Publication: US 2017/0313717
Novel Glp-1 Receptor Modulators
Application: 15/711,858 →
Publication: US 2018/0021346
CXCR3 Receptor Agonists
Application: 16/335,641 →
Publication: US 2019/0345133
Compounds and Methods for Treating Lupus
Application: 16/337,292 →
Publication: US 2019/0224172
Dimethylaminoethanol Salt of a Glp-1 Receptor Modulator
Application: 16/337,298 →
Publication: US 2020/0131164
Glp-1 Receptor Modulators
Application: 16/608,134 →
Publication: US 2021/0371409
Sphingosine 1 Phosphate Receptor Agonists for Neuroprotection
Application: 16/611,451 →
Publication: US 2020/0085795
Sphingosine 1-Phosphate Modulators
Application: 61/261,282 →
Novel Heterocyclic Sphingosine 1-Phosphate Modulators
Application: 61/261,295 →
Selective Sphingosine 1 Phosphate Modulators and Methods of Chiral Synthesis
Application: 61/261,301 →
Selective Sphingosine 1 Phosphate Modulators and Methods of Chiral Synthesis
Application: 61/262,474 →
Novel Glp-1 Receptor Stabilizers and Modulators
Application: 61/353,174 →
Novel Fusion Partners for the Purpose of Crystallizing G-Protein Coupled Receptors
Application: 61/485,872 →
Selective Heterocyclic Sphingosine 1 Phosphate Receptor Modulators
Application: 61/486,184 →
Novel Glp-1 Receptor Stabilizers and Modulators
Application: 61/491,446 →
Novel Glp-1 Receptor Stabilizers and Modulators
Application: 61/535,750 →
Novel Glp-1 Receptor Stabilizers and Modulators
Application: 61/569,754 →
Novel Glp-1 Receptor Stabilizers and Modulators
Application: 61/569,759 →
Novel Glp-1 Receptor Stabilizers and Modulators
Application: 61/570,789 →
Alternate Fusion Partners for Gpcr Crystallization
Application: 61/618,424 →
Novel Glp-1 Receptor Modulators
Application: 61/734,300 →
Novel Glp-1 Receptor Modulators
Application: 61/833,737 →
Selective Sphingosine 1 Phosphate Receptor Modulators and Combination Therapy Therewith
Application: 61/898,971 →
Novel Glp-1 Receptor Modulators
Application: 61/981,643 →
Novel Glp-1 Receptor Modulators
Application: 62/028,962 →
Novel Glp-1 Receptor Modulators
Application: 62/090,040 →
Novel Glp-1 Receptor Modulators
Application: 62/090,268 →
Novel Glp-1 Receptor Modulators
Application: 62/161,650 →
Novel Glp-1 Receptor Modulators
Application: 62/161,658 →
Novel Glp-1 Receptor Modulators
Application: 62/164,113 →
CXCR3 Receptor Agonists
Application: 62/383,202 →
Compounds and Methods for Treating Lupus
Application: 62/401,762 →
Dimethylaminoethanol Salt of a Glp-1 Receptor Modulator
Application: 62/402,565 →
CXCR3 Receptor Agonists
Application: 62/478,496 →
Novel Glp-1 Receptor Modulators
Application: 62/491,892 →
Neuroprotective Agents and Methods Related Thereto
Application: 62/502,909 →
Ozanimod Demonstrates Preservation of Brain Volume at 1 and 2 Years in Two Phase 3 Trials of Relapsing Multiple Sclerosis
Application: 62/544,467 →
Sphingosine 1 Phosphate Receptor Modulators
Application: 62/826,769 →
Sphingosine 1 Phosphate Receptor Modulators
Application: 62/826,778 →
Sphingosine 1 Phosphate Receptor Modulators
Application: 62/826,794 →
Sphingosine 1 Phosphate Receptor Modulators
Application: 62/826,797 →
Sphingosine 1 Phosphate Receptor Modulator
Application: 62/839,495 →
Sphingosine 1 Phosphate Receptor Modulators
Application: 63/001,073 →
Sphingosine 1 Phosphate Receptor Modulators
Application: 63/001,085 →
Sphingosine 1 Phosphate Receptor Modulators
Application: 63/001,090 →
Sphingosine 1 Phosphate Receptor Modulators
Application: 63/018,327 →
Sphingosine 1 Phosphate Receptor Modulators
Application: 63/018,333 →
Sphingosine 1 Phosphate Receptor Modulators
Application: 63/018,347 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 29, 2011
From: MARTINBOROUGH, ESTHER; BOEHM, MARCUS F.; YEAGER, ADAM RICHARD; TAMIYA, JUNKO
To: RECEPTOS, INC.
Reel/Frame 026041/0498 →
Assignment of Assignor's Interest Mar 29, 2011
From: BOEHM, MARCUS F.; MARTINBOROUGH, ESTHER; BRAHMACHARY, ENUGURTHI; MOORJANI, MANISHA
To: RECEPTOS, INC.
Reel/Frame 026041/0818 →
Assignment of Assignor's Interest Mar 29, 2011
From: MARTINBOROUGH, ESTHER; BOEHM, MARCUS F.; YEAGER, ADAM RICHARD; TAMIYA, JUNKO
To: RECEPTOS, INC.
Reel/Frame 026041/0665 →
Assignment of Assignor's Interest Jul 25, 2011
From: BOEHM, MARCUS F.; MARTINBOROUGH, ESTHER; MOORJANI, MANISHA; HUANG, LIMING
To: RECEPTOS, INC.
Reel/Frame 026642/0552 →
Confirmatory License Sep 27, 2012
From: THE SCRIPPS RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029045/0537 →
Assignment of Assignor's Interest Mar 19, 2013
From: MARTINBOROUGH, ESTHER; BOEHM, MARCUS F.; YEAGER, ADAM RICHARD; TAMIYA, JUNKO
To: RECEPTOS, INC.
Reel/Frame 030044/0887 →
Assignment of Assignor's Interest Mar 19, 2013
From: MARTINBOROUGH, ESTHER; BOEHM, MARCUS F.; YEAGER, ADAM RICHARD; TAMIYA, JUNKO
To: RECEPTOS, INC.
Reel/Frame 030044/0922 →
Assignment of Assignor's Interest Mar 19, 2013
From: MARTINBOROUGH, ESTHER; BOEHM, MARCUS F.; YEAGER, ADAM RICHARD; TAMIYA, JUNKO
To: RECEPTOS, INC.
Reel/Frame 030044/0907 →
Assignment of Assignor's Interest Mar 20, 2013
From: BOEHM, MARCUS F.; MARTINBOROUGH, ESTHER; BRAHMACHARY, ENUGURTHI; MOORJANI, MANISHA
To: RECEPTOS, INC.
Reel/Frame 030051/0932 →
Assignment of Assignor's Interest Mar 21, 2013
From: BOEHM, MARCUS F.; MARTINBOROUGH, ESTHER; MOORJANI, MANISHA; HUANG, LIMING
To: RECEPTOS, INC.
Reel/Frame 030058/0758 →
Assignment of Assignor's Interest Mar 21, 2013
From: BOEHM, MARCUS F.; MARTINBOROUGH, ESTHER; MOORJANI, MANISHA; TAMIYA, JUNKO
To: RECEPTOS, INC.
Reel/Frame 030056/0665 →
Assignment of Assignor's Interest Mar 29, 2013
From: BOEHM, MARCUS F.; MARTINBOROUGH, ESTHER; MOORJANI, MANISHA; TAMIYA, JUNKO
To: RECEPTOS, INC.
Reel/Frame 030113/0273 →
Assignment of Assignor's Interest Mar 29, 2013
From: BOEHM, MARCUS F.; MOORJANI, MANISHA; TAMIYA, JUNKO; HUANG, LIMING
To: RECEPTOS, INC.
Reel/Frame 030113/0243 →
Assignment of Assignor's Interest Apr 15, 2013
From: MARTINBOROUGH, ESTHER; BOEHM, MARCUS F.; YEAGER, ADAM RICHARD; TAMIYA, JUNKO
To: RECEPTOS, INC.
Reel/Frame 030218/0056 →
Assignment of Assignor's Interest Nov 12, 2013
From: STEVENS, RAYMOND C.; KUNKEN, JOSHUA; THOMPSON, AARON A.; LIU, WEI
To: SCRIPPS RESEARCH INSTITUTE, THE
Reel/Frame 031702/0042 →
Assignment of Assignor's Interest Feb 21, 2014
From: HANSON, MICHAEL A.; ROTH, CHRISTOPHER B.; GRIFFITH, MARK T.
To: RECEPTOS, INC.; THE SCRIPPS RESEARCH INSTITUTE
Reel/Frame 032261/0270 →
Assignment of Assignor's Interest Mar 20, 2015
From: CHEREZOV, VADIM
To: THE SCRIPPS RESEARCH INSTITUTE
Reel/Frame 035211/0972 →
Assignment of Assignor's Interest Mar 23, 2015
From: BOEHM, MARCUS F.; MARTINBOROUGH, ESTHER; BRAHMACHARY, ENUGURTHI; MOORJANI, MANISHA
To: RECEPTOS, INC.
Reel/Frame 035235/0078 →
Assignment of Assignor's Interest Jun 16, 2015
From: BOEHM, MARCUS F.; MARTINBOROUGH, ESTHER; MOORJANI, MANISHA; TAMIYA, JUNKO
To: RECEPTOS, INC.
Reel/Frame 035923/0241 →
Assignment of Assignor's Interest Jun 16, 2015
From: BOEHM, MARCUS F.; MARTINBOROUGH, ESTHER; MOORJANI, MANISHA; TAMIYA, JUNKO
To: RECEPTOS, INC.
Reel/Frame 035920/0325 →
Change of Name Sep 9, 2016
From: RECEPTOS, INC.
To: RECEPTOS LLC
Reel/Frame 039977/0239 →
Assignment of Assignor's Interest Sep 12, 2016
From: RECEPTOS LLC
To: CELGENE INTERNATIONAL II SÀRL
Reel/Frame 040002/0196 →
Assignment of Assignor's Interest Nov 29, 2017
From: BOEHM, MARCUS F.; MARTINBOROUGH, ESTHER; MOORJANI, MANISHA; TAMIYA, JUNKO
To: CELGENE INTERNATIONAL II SÀRL
Reel/Frame 044248/0324 →
Confirmatory License Jan 21, 2018
From: THE SCRIPPS RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 044683/0124 →
Assignment of Assignor's Interest Aug 16, 2022
From: FOWLER, THOMAS; IACOBINI, GREG P.; CRITTALL, MATTHEW RICHARD
To: SYGNATURE DISCOVERY LIMITED
Reel/Frame 060822/0346 →